谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase I Study of a Recombinant Attenuated Oncolytic Virus, MEDI5395 (NDV-GM-CSF), Administered Systemically in Combination with Durvalumab in Patients with Advanced Solid Tumors

Diwakar Davar,Benedito A. Carneiro,Grace K. Dy,Siddharth Sheth,Mitesh J. Borad,Kevin J. Harrington,Sandip P. Patel,Evanthia Galanis,Adel Samson,Sonia Agrawal, Zhongying Chen, Chunling Fan,Maozhen Gong, Jenny Burton,Eric Tu,Nicholas Durham, Kevin Laubscher, Fernanda Arnaldez,Dmitriy Zamarin

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2024）

引用 0|浏览2
关键词
Pharmacokinetics - PK,Immune Checkpoint Inhibitor,Oncolytic virus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要